The new criteria for classification of Rheumatoid Arthritis have been recently released. They incorporate the anti-Citrullinated Protein antibody testing and the other classic criteria in a score system (the diagnosis of definite rheumatoid arthritis is made by a total score ≥6). These criteria try to meet the pressing needs to gain sensitivity in early disease. Symptoms, elevated acute-phase response, serologic abnormality, joint involvement were all considered for scoring after confirming the presence of synovitis in at least 1 joint in the absence of an alternative diagnosis that better explains the synovitis. However, no sensitivity and specificity has been showed. Moreover, Area Under Curve of the Receiver Operating Characteristic curves (a measure of performance of the test) was not optimal in almost two of the three studied cohorts. On the contrary, the old criteria of the American College of Rheumatology had been tested to calculate sensitivity and specificity. Moreover, sensitivity and specificity of anti-citrullinated peptide auto-antibodies are available for clinical reasoning based on pre-test and post-test probabilities of the disease. The use of likelihood ratios applied to both the old criteria and anti-citrullinated autoantibodies could help clinicians to effectively manage early arthritis patients implementing Bayesian reasoning. Here, we tried to explain the methodology applied to the body of knowledge currently available about rheumatoid arthritis for diagnostic decisionmaking based on the Bayesian approach.
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The 2010 Rheumatoid Arthritis classification criteria were recently published [1] . They try to meet the pressing needs to gain sensitivity in early disease. Symptoms, elevated acute-phase response, serologic abnormality, joint involvement were all considered for scoring after confirming the presence of synovitis in at least 1 joint in the absence of an alternative diagnosis that better explains the synovitis (Table 1) . Anti-Citrullinated Protein antibody testing was incorporated for the first time into the new diagnostic criteria. However, various issues should be addressed. First of all, the paper does not report any sensitivity and specificity of the new criteria whereas the old criteria had reported these values. The whole formulation process was based on a form of structured consent by expert opinion. On the contrary, since three large cohorts were available, a statistically driven process could be used to weight each criterion by likelihood ratios. Positive and negative likelihood ratios (and their 95% Confidence Intervals) could be computed for groups with similar criteria. Thus, the property of combining independent likelihood ratios could have been used for implementation in clinical practice. Unfortunately, for these reasons, the opportunity to put into practice an intriguing evidence based approach has been missed out. Last but not least, the great effort that was made seems to have brought forth a mouse. If, on one hand, either sensitivity and specificity or likelihood ratios were not reported, on the other hand, the overall accuracy seems poor. In particular, the Area Under Curve for Receiver Operating Characteristic curves (which plot sensitivity, or true positive rate, against 1-specificity, or false positive rate, to individuate the best discriminating cut-off value of a quantitative variable, as a score is) resulted good in the Norwegian cohort (0.88) but insufficient in both the French and Rotterdam ones (b0.70). Even though they were always statistically significant, notable variability among the Receiver Operating Characteristic curves of the three different cohorts raises many doubts about clinical significance. However, clinicians need clinically significant tools for clinical practice where statistical significance is only a necessary but not a sufficient criterion. On the other hand, the old criteria were developed in the 1987 revision using the method of classification trees. This analysis pointed out a specificity of 89% and a sensitivity of about 84% for the rule requiring 4 out of 7 American College of Rheumatology criteria. Moreover, in recent years, the anti-Citrullinated Peptide autoantibodies have emerged as valuable serologic marker of Rheumatoid Arthritis while Rheumatoid Factor is the only biomarker Contents lists available at ScienceDirect
European Journal of Internal Medicine j o u r n a l h o m e p a g e : w w w. e l s ev i e r. c o m / l o c a t e / e j i m considered by the above-mentioned old American College of Rheumatology criteria. The importance of anti-Citrullinated Peptide autoantibodies consists in the best specificity in comparison with Rheumatoid Factor in patients affected by early Rheumatoid Arthritis [2, 3] . Recently, a systematic review has been published on accuracy of anti-Citrullinated Peptide autoantibodies for diagnosing early RA [4] . This analysis of 151 studies showed that sensitivity and specificity were 57% (95% Confidence Intervals, 51% to 63%) and 96% (93% to 97%), respectively (analysis refers only to 15 relevant cohort studies). Thus, sensitivity and specificity of the old American College Rheumatoid criteria are available to us as much the same data for anti-Citrullinated Peptide antibodies. How can this information be utilized for clinical practice? Sensitivity and specificity are stable characteristic of a test. The Bayes' theorem demonstrates that the Likelihood Ratio of both a positive and negative test allows to compute posterior probability using different "a priori" probabilities [5] . In a few words Likelihood Ratios are sufficiently stable characteristic of a test with more informative power than sensitivity and specificity (usually cryptic information for the clinician). Indeed, sensitivity and specificity are useful parameters when they reach values near 100% (a negative result of a test with sensitivity of 100% permits to exclude a disease while a test with specificity of 100% is highly indicative of disease when it results positive). On the contrary, Likelihood Ratio of a positive test and of a negative one are always informative and easily usable. Generally, a positive Likelihood Ratio N15 suggests a good probability to diagnose a disease while a negative Likelihood Ratio b0.15 suggests a good probability to exclude a disease [6] . Archibald Cochrane claimed needs for synthesis caused by information overload [8] . The Cochrane network systematic reviews have become the standard to summarize information toward knowledge growth [9] . Now, we also need to organize information to generate usable knowledge using both the available methodology from clinical epidemiology and clinical research data [10] . We believe that what we have explained in this manuscript goes toward this direction. Scientific community and prominent journals oriented to readership of clinical practitioners must continue to provide knowledge support for ease clinical practice implementation. We strongly claim that scientific knowledge had to be based on facts and not on faith.
Learning points
• The new criteria for classification of Rheumatoid Arthritis incorporate the anti-Citrullinated Protein antibody testing and the other classic criteria in a score system. The diagnosis of definite rheumatoid arthritis is made by a total score ≥6. These criteria might be more useful for classification of patients with early arthritis disease. However, no sensitivity and specificity has been showed. Moreover, Area Under Curve of the Receiver Operating Characteristic curves (a measure of performance of the test) was not optimal in almost two of the three studied cohorts.
• On the contrary, the old criteria of the American College of Rheumatology had been tested to calculate sensitivity and specificity. Moreover, sensitivity and specificity of anti-citrullinated peptide auto-antibodies are available for clinical reasoning based on pre-test and post-test probabilities of the disease. The use of likelihood ratios (see the text) applied to both the old criteria and anti-citrullinated autoantibodies could help clinicians to effectively manage early arthritis patients implementing Bayesian reasoning.
• Less than four of the old classification criteria and negative anticitrullinated peptide autoantibodies allow to exclude rheumatoid arthritis.
• Even If a patient had not sufficient probability of disease (below four of the old criteria) but the anti-citrullinated peptide autoantibodies N15 U/mL, the diagnosis of rheumatoid arthritis could be set. "Large joints" refers to shoulders, elbows, hips, knees, and ankles. "Small joints" refers to the metacarpophalangeal joints, proximal interphalangeal joints, second through fifth metatarsophalangeal joints, thumb interphalangeal joints, and wrists. For more details, please refer to the main publication (1). The diagnosis of definite rheumatoid arthritis is made by a total score ≥ 6. RF: Rheumatoid Factor; ACPA: Anti-Citrullinated Peptide Autoantibodies; CRP:C Reactive Protein; ESR: Erythrocyte Sedimentation Rate.
